Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injuries Behavior Associated With Prader-Willi Syndrome

Phase 4

Withdrawn

Conditions: Prader-Willi Syndrome

Interventions: Other: Placebo
Drug: Guanfacine extended release (GXR)

First Posted Date: 2019-08-26

Last Posted Date: 2020-08-26

Lead Sponsor: NYU Langone Health

Registration Number: NCT04066088

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

CTCs in Cervix Cancer

Completed

Conditions: HPV
Cervical Cancer

Interventions: Diagnostic Test: Blood Assayed for CTCs

First Posted Date: 2019-08-22

Last Posted Date: 2022-08-05

Lead Sponsor: NYU Langone Health

Target Recruit Count: 4

Registration Number: NCT04064515

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Electronic Cigarettes as a Harm Reduction Strategy in Individuals With Substance Use Disorder

Phase 2

Completed

Conditions: Cigarette Smoking
E Cig Use
Addiction

Interventions: Device: E cigarettes
Other: Nicotine Replacement Therapy

First Posted Date: 2019-08-21

Last Posted Date: 2024-12-20

Lead Sponsor: NYU Langone Health

Target Recruit Count: 48

Registration Number: NCT04063267

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Parent Understanding of Discharge Instructions

Not Applicable

Terminated

Conditions: Parent-Child Relations

Interventions: Other: Provider Training
Other: Health Literacy-Informed Discharge Instructions

First Posted Date: 2019-08-21

Last Posted Date: 2024-05-31

Lead Sponsor: NYU Langone Health

Target Recruit Count: 264

Registration Number: NCT04063241

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer

Recruiting

Conditions: Lung Cancer

Interventions: Other: Bronchoscopy
Other: Research Procedures

First Posted Date: 2019-08-21

Last Posted Date: 2025-01-29

Lead Sponsor: NYU Langone Health

Target Recruit Count: 40

Registration Number: NCT04063501

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

High Level Mobility Training in Ambulatory Patients With Acquired Non-progressive Central Neurological Injury

Not Applicable

Terminated

Conditions: Neurological Injury

Interventions: Other: Complex Skill Group
Other: Simple Skill Group

First Posted Date: 2019-08-21

Last Posted Date: 2020-08-11

Lead Sponsor: NYU Langone Health

Target Recruit Count: 28

Registration Number: NCT04063228

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Neural Mechanisms of Cost and Benefit Integration During Decision-Making, Aim 2: Acute & Lifetime Stress

Completed

Conditions: Healthy

Interventions: Behavioral: Control CPT
Behavioral: Cold-Pressor Task (CPT)
Device: fMRI

First Posted Date: 2019-08-19

Last Posted Date: 2023-07-25

Lead Sponsor: NYU Langone Health

Target Recruit Count: 397

Registration Number: NCT04060966

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Craniomaxillofacial and Upper Extremity Allotransplantation

Not Applicable

Recruiting

Conditions: Craniofacial Injuries
Upper Extremity Injuries
Face Injuries
Hand Injuries
Facial Injuries
Facial Deformity

Interventions: Procedure: Combined Craniomaxillofacial and Upper Extremity Allotransplantation

First Posted Date: 2019-08-15

Last Posted Date: 2025-01-31

Lead Sponsor: NYU Langone Health

Target Recruit Count: 10

Registration Number: NCT04057638

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Bronchoscopic Cryo-Immunotherapy of Lung Cancer

Early Phase 1

Completed

Conditions: Advanced Non-small Cell Lung Cancer

Interventions: Device: ERBOKRYO® CA - Cryosurgical Unit with Flexible ERBECRYO Probe, 1.9 mm outer diameter (ERBE Inc., Tubingen, Germany)

First Posted Date: 2019-08-08

Last Posted Date: 2025-04-24

Lead Sponsor: NYU Langone Health

Target Recruit Count: 21

Registration Number: NCT04049474

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Nivolumab Combined With BMS-986253 in HCC Patients

Phase 2

Completed

Conditions: Hepatocellular Carcinoma

Interventions: Drug: Nivolumab 240 mg IV every 2 weeks
Drug: Nivolumab 240 mg IV every 2 weeks + BMS-986253 1200 mg IV every 2 weeks
Drug: Nivolumab 240 mg IV every 2 weeks + Cabiralizumab 4 mg/kg IV every 2 weeks

First Posted Date: 2019-08-08

Last Posted Date: 2025-05-06

Lead Sponsor: NYU Langone Health

Target Recruit Count: 23

Registration Number: NCT04050462

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy